Answers are grounded in this paper and cite their sources.
Develops a predictive model for severe deterioration in gallstone disease, highlighting its practical use.
Patients with gallstone-related biliary disease may deteriorate rapidly before definitive source control. This study aimed to develop an interpretable 0-24-hour prediction model for short-term severe deterioration in gallstone-related biliary disease and validate it across eICU-CRD and a local real-world cohort. MIMIC-IV was used for model development, eICU-CRD for primary external validation, and local clinical data for secondary validation. Eligible patients had gallstone disease, cholecystitis, cholangitis, or biliary obstruction. The outcome was a composite of in-hospital or ICU death, vasopressor use, mechanical ventilation, continuous renal replacement therapy, or prolonged ICU stay. Feature selection, imputation, scaling, model selection, and threshold determination were restricted to MIMIC-IV development data. Performance was assessed using AUROC, AUPRC, Brier score, calibration, decision curves, threshold consequences, subgroup analyses, bootstrap risk uncertainty, and SHAP explanations. The study included 2818 MIMIC-IV stays, 1492 eICU-CRD stays, and 115 local patients, with event rates of 58.4%, 65.7%, and 52.2%, respectively. The locked elastic net model retained 12 routine early predictors. AUROC was 0.70 in MIMIC-IV internal validation, 0.64 in eICU-CRD external validation, and 0.63 in local validation. Calibration, net benefit, threshold consequences, and SHAP analyses supported use as a bedside risk-support tool rather than a replacement for clinical judgment. A routine early model captured multi-system deterioration signals in gallstone-related biliary disease and showed transportable, moderate discrimination across external cohorts.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: